Karel Helman

517 total citations
17 papers, 370 citations indexed

About

Karel Helman is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Karel Helman has authored 17 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Karel Helman's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Climate Change Policy and Economics (2 papers). Karel Helman is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Climate Change Policy and Economics (2 papers). Karel Helman collaborates with scholars based in Czechia, Russia and United States. Karel Helman's co-authors include Jarmila Zimmermannová, Miroslav Hájek, Pavel Klener, Petra Vočková, Marek Trněný, Milan Bašta, Magdalena Klánová, Ladislav Anděra, Miroslav Hájek and J. Soukup and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Karel Helman

16 papers receiving 363 citations

Peers

Karel Helman

RESE

ONCOL

PFM

Margarita Ortega Spain

Shruti Agrawal India

Hongye Sun China

Wenlong Zhou China

Fabrizio Patriarca Italy

Xuhua Hu China

Т. А. Невзорова Russia

Sufeng Li China

Katja Schumacher Germany

Margarita Ortega Spain

Karel Helman

55 ×0.4

46 ×0.5

RESE

47 ×0.5

31 ×0.4

ONCOL

52 ×0.8

PFM

Citations per year, relative to Karel Helman Karel Helman (= 1×) peers Margarita Ortega

Countries citing papers authored by Karel Helman

Since Specialization

Citations

This map shows the geographic impact of Karel Helman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Helman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Helman more than expected).

Fields of papers citing papers by Karel Helman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karel Helman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Helman. The network helps show where Karel Helman may publish in the future.

Co-authorship network of co-authors of Karel Helman

This figure shows the co-authorship network connecting the top 25 collaborators of Karel Helman. A scholar is included among the top collaborators of Karel Helman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Helman. Karel Helman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Klánová, Magdalena, Eva Pokorná, Marek Mráz, et al.. (2024). Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status. Blood Advances. 8(13). 3532–3543. 4 indexed citations

Jorda, Radek, Ondřej Havránek, Eva Pokorná, et al.. (2022). Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BH3-Mimetics in Experimental Models of Relapsed/Refractory Mantle Cell Lymphoma. Blood. 140(Supplement 1). 5996–5997. 2 indexed citations

Helman, Karel, et al.. (2021). Do informal reasoning fallacies really shape decisions? Experimental evidence. Rationality and Society. 33(4). 448–479. 2 indexed citations

Hájek, Miroslav, Jarmila Zimmermannová, & Karel Helman. (2021). Environmental efficiency of economic instruments in transport in EU countries. Transportation Research Part D Transport and Environment. 100. 103054–103054. 24 indexed citations

Jorda, Radek, Eva Pokorná, Ondřej Havránek, et al.. (2021). Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BCL2 Inhibitor Venetoclax in Experimental Models of Chemotherapy Refractory Mantle Cell Lymphoma. Blood. 138(Supplement 1). 1203–1203. 1 indexed citations

Helman, Karel, et al.. (2020). PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population. Folia Biologica. 66(4). 117–122. 4 indexed citations

Pola, Robert, Eva Pokorná, Petra Vočková, et al.. (2020). Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma. Acta Biomaterialia. 119. 349–359. 12 indexed citations

Klener, Pavel, Petra Vočková, Eva Pokorná, et al.. (2020). Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab. Journal of Controlled Release. 328. 160–170. 14 indexed citations

Průková, Dana, Ladislav Anděra, Zuzana Nahácka, et al.. (2019). Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma. Clinical Cancer Research. 25(14). 4455–4465. 63 indexed citations

10.

Helman, Karel, et al.. (2019). RELATIONSHIP BETWEEN EMPLOYMENT AND EFFECTIVE TAXATION OF LABOUR ON ENTERPRISE LEVEL IN EU. Ekonomický časopis (Journal of Economics). 67(1). 1 indexed citations

11.

Hájek, Miroslav, et al.. (2019). Analysis of carbon tax efficiency in energy industries of selected EU countries. Energy Policy. 134. 110955–110955. 143 indexed citations

12.

Helman, Karel, et al.. (2018). EVS data-based analysis of tax evasion: Descriptive vs. regression modelling. Society and Economy. 40(1). 89–103. 4 indexed citations

13.

Klánová, Magdalena, Ladislav Anděra, Jan Bražina, et al.. (2015). Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma. Clinical Cancer Research. 22(5). 1138–1149. 72 indexed citations

14.

Klánová, Magdalena, Ladislav Anděra, J. Soukup, et al.. (2014). MCL1 Targeting Agent Homoharringtonine Exerts Strong Cytotoxicity Towards Diffuse Large B-Cell Lymphoma (DLBCL) Cells and Synergizes with BCL2 Targeting Agent ABT199 in Eliminating BCL2-Positive DLBCL Cells. Blood. 124(21). 3645–3645. 3 indexed citations

15.

Helman, Karel, et al.. (2013). Sustainable Development Indicators at the Regional Level in the Czech Republic. SHILAP Revista de lepidopterología. 4 indexed citations

16.

Bašta, Milan & Karel Helman. (2013). Scale-specific importance of weather variables for explanation of variations of electricity consumption: The case of Prague, Czech Republic. Energy Economics. 40. 503–514. 16 indexed citations

17.

Helman, Karel. (2006). Postavy imigrantek v dílech současných amerických etnických autorek. Digital Repository (National Repository of Grey Literature). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact